The number of dangerous and costly central-line-associated bloodstream infections is dropping, according to the Centers for Disease Control and Prevention. In its first state-specific report on healthcare-associated infections, the CDC determined that the number of central-line-associated bloodstream infections was 18% lower than predicted during the first six months of 2009.
CDC sees progress against central-line infections
That improvement reflects increased participation in national prevention initiatives, broader implementation of quality guidelines and improved practices at the local level, said Arjun Srinivasan, associate director for healthcare-associated infection prevention programs at the CDC’s Healthcare Quality Promotion Division.
CDC researchers utilized data from 1,538 facilities across the country that use the agency’s National Healthcare Safety Network, or NHSN, a public surveillance resource created for reporting healthcare-associated infections. While only 17 states currently mandate NHSN reporting of central-line-associated bloodstream infections, more states are making the move toward across-the-board requirements, said Don Wright, HHS’ deputy assistant secretary for healthcare quality, during a teleconference.
There is a lot more work to be done to eliminate these types of infections, but the report indicates that progress is being made, Srinvasan said. He also added that the infection rates in the report can serve as a baseline for states as they push new improvement programs forward.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.